Tag: Generics

A new drug assessment method developed in Russia

Russian scientists proposed a new method for assessing the medicines that will allow to avoid testing drugs in humans

Glenmark entered exclusive agreement with Cyndea Pharma

Glenmark Pharmaceuticals, a global pharmaceutical company, yesterday announced it has entered into a development, license, manufacture and commercial supply agreement with Spanish company Cyndea Pharma S.L.

EC suspects Teva in EU antitrust rules violation

The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of EU antitrust rules

Sandoz obtained EU approval for Rixathon

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced today that the European Commission (EC) has approved Rixathon

Market share of Russian-made cancer drugs reached 75-80% within three years

The share of Russian-made drugs for treatment and prevention of oncological diseases in the domestic market reached 75-80% in three years

Baxter announced R&D collaboration with Dorizoe Lifesciences

Baxter International Inc., a global medical products company, announced an agreement with Dorizoe Lifesciences Limited

Natco Pharma released generic hepatitis C drug in India

Natco Pharma Limited announced today that it has launched a generic version of Sofosbuvir 400 mg / Velpatasvir 100 mg fixed dose combination in India. Sofosbuvir 400 mg / Velpatasvir 100 mg fixed ...

WHO will attempt to make biosimilar drugs more accessible

This year World Health Organisation (WHO) will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely availab...

Russia approved WTO protocol for the compulsory licensing of pharmaceuticals

drug manufacturing
At a meeting held on April 27, 2017, the Government of the Russian Federation approved the draft federal law "On the Adoption of Protocol Amending the Agreement on Trade-Related Aspects of the Intelle...

Sawai Pharmaceutical buys Upsher-Smith Laboratories

Sawai Pharmaceutical Co. Ltd, a leading Japanese generic pharmaceuticals manufacturer, and Upsher-Smith Laboratories, Inc., an established generics manufacturer based in Minnesota, U.S., today announc...

Generics manufacturers strengthen positions in Russian pharmaceutical market

The long market slowdown which began with acute phase of the crisis ended only in Q4 2016. Last year was marked by the loss of leading positions and a drop in retail sales of original medicinal produc...

EMA put off the registration of more than 300 generic medicines

EU flag
The European Medicines Agency (EMA) has recommended suspending a number of nationally approved medicines for which bioequivalence studies were conducted by Micro Therapeutic Research Labs at two sites...

Biogaran will manufacture generic drugs in Nigeria

Biogaran, a French pharmaceutical company specialized in generic and biosimilar medicines, and a subsidiary of Servier, announced the takeover of all the activities of Swipha, a Nigerian company that ...

Two Indian companies can export Bayer drugs for R&D

An Indian court granted a pair of drugmakers the right to export the main ingredients of two of Bayer AG’s top-selling drugs to develop generics in other countries, a decision that has the potential t...

The future of generics and strategies for commercial success

GBI Research examines whether the US continue to dominate the global generic drug market. The US continues to be the largest generic drugs market by revenue. Its market is primarily driven by compe...

More than 20 medicines have been launched to the Russian market

pharma skolkovo
The results of project implementation were discussed at the meeting of the general committee of the Presidential Council of the Russian Federation for Economic Modernization and Innovative Development...